Physician profile
Frederick Quirante
NPI 1023063195
$11,696.76
in general payments reported to CMS, 2019-2025
10 companies · $92.03 in 2025
The $92.03 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,301 · 2020: $729 · 2021: $893 · 2022: $6,827 · 2023: $218 · 2024: $1,636 · 2025: $92.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,207 · Food and Beverage: $739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,206.99 |
| Food and Beverage | $739.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $8,558.59 | 2019-2024 | Grafix Pl, Stravix, Collagenase Santyl |
| Medical Device Business Services, INC. | $1,325.99 | 2024 | |
| Arthrosurface Incorporated | $1,120.71 | 2019 | |
| Depuy Synthes Sales INC. | $221.48 | 2024-2025 | Motoband, Na, N/A |
| Osiris Therapeutics INC. | $131.92 | 2019 | |
| Melinta Therapeutics, LLC | $104.40 | 2020-2022 | |
| Averitas Pharma INC. | $102.50 | 2024 | Qutenza |
| Tactile Systems Technology INC | $56.84 | 2021 | |
| Abbvie INC. | $52.16 | 2022-2023 | |
| Esaote North America, INC. | $22.17 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Quirante listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.